AURELIUS reports record results in the first half of 2014

14.08.2014

AURELIUS reports record results in the first half of 2014

  • Revenues increase to EUR 804 million despite disposals
  • Consolidated EBITDA rises 128 percent to EUR 111.5 million
  • Consolidated net profit totals EUR 57.9 million
  • Executive Board raises profit forecast for 2014: EBITDA of at least EUR 220 million (previously at least EUR 200 million)
  • Further intensive transaction activity expected in the second half of 2014

Munich, August 14, 2014 – The AURELIUS Group (ISIN DE000A0JK2A8) generated total consolidated revenues of EUR 804.0 million in the first half of 2014 (first half of 2013: EUR 765.1 million). Annualized consolidated revenues increased to EUR 1,625.5 million. The good performance of the Group companies, three new acquisitions and two disposals in the first half of 2014 helped the EBITDA for the Group as a whole to more than double during the first half of 2014, to reach EUR 111.5 million (first half of 2013: EUR 48.9 million). This figure does not include the acquisitions of IDS Individual Desktop Services or Scholl Footwear. Both transactions are scheduled for completion during the course of the third quarter.

Following two further successful exits – Hungary-based Framochem and Switzerland-based connectis AG – to be completed in the third quarter of 2014, the Executive Board is raising its forecast for aggregate EBITDA to at least EUR 220 million (previously at least EUR 200 million).

Successful transactions boost results

The total EBITDA of the AURELIUS Group of EUR 111.5 million includes income of EUR 43.6 million (first half of 2013: EUR 13.6 million) from the reversal of negative goodwill (bargain purchase income) from the companies acquired during the first half of 2014 – the IT consulting activities of Telvent Global Services in Spain and South America, the AKAD University and the international advertising marketer Publicitas. Set against this are restructuring and non-recurring expenses of EUR 15.3 million (first half of 2013: EUR 14.7 million). The successful sale of the healthcare activities of brightONE to T-Systems with effect from January 31, 2014 and the sale of Reederei Peter Deilmann to Callista Private Equity yielded a gain of EUR 32.0 million (first half of 2013: EUR 0 million). The operating EBITDA of EUR 51.2 million for the Group as a whole is at the same level as last year (first half of 2013: EUR 50.0 million) accordingly, despite negative effects arising from the acquisitions completed in the first half of the year.

The cash flow from operating activities rose sharply, to EUR 39.4 million (first half of 2013: EUR 29.4 million). Cash and cash equivalents totaled EUR 239.4 million at the end of the first half of 2014 (December 31, 2013: EUR 223.9 million), while the consolidated equity ratio amounted to 29 percent (December 31, 2013: 30%).

Further lucrative disposals and intensive transaction activity in the third quarter

With the sale of ISOCHEM`s Hungary-based subsidiary Framochem to US-based VanDeMark Chemical Inc. and Switzerland-based connectis AG to the France-based SPIE Group in the third quarter, AURELIUS has already achieved four successful exits in 2014. These two disposals will have a positive impact on results in the third quarter of the current year worth in the mid-double digit millions of euros. The acquisition of Scholl`s shoe business from UK-based Reckitt Benckiser, which will similarly have a positive impact on results in the third quarter, represents a further step in the increasing internationalization of AURELIUS. The Group has expanded its international presence by opening an office in Stockholm. The Executive Board expects transaction activity to remain intensive over the rest of the year as well.

Outlook for 2014 as a whole

"We`re well on track to break all records for AURELIUS in 2014. Our portfolio companies are performing well overall and we are seeing huge interest on the acquisition side as well as for the disposal of portfolio companies," says AURELIUS CEO Dr. Dirk Markus. "The second half of the year is set to remain really busy." 

Key figures (in EUR millions)

 

 

01/01 - 06/30/2014

01/01 -  06/30/2013

Change

Total consolidated revenues  

   804.0

765.1

+ 5%

Consolidated revenues (annualized) ²

  1,625.5

 1,160.0

+ 40%

Total consolidated EBITDA

   111.5

  48.9

+ 128%

of which income from the reversal of negative goodwill

 

 

 

(bargain purchase income)

 43.6

 13.6

 + 221%

of which restructuring and non-recurring expenses

- 15.3

 - 14.7

+ 4%

of which income from the disposal of companies above book value

32.0

-        / -

-        / -

Consolidated operating EBITDA

51.2

 50.0

+ 2%

Consolidated profit/loss ¹

 57.9

 0.2

+ > 100%

Earnings per share

 

 

 

  basic ¹`² (in EUR)

1.79

 0.14

 + > 100%

  diluted ¹`² (in EUR)

 1.79

0.14

 + > 100%

Cash flow from operating activities ¹

 39.4

 29.4

 + 34%

Cash flow from investing activities ¹

 7.0

 - 3.1

 + > 100%

Free cash flow ¹

 46.4

 26.3

 + 76%

 

6/30/2014

12/31/2013

Change

Assets

 1,365.2

1,215.4

 + 12%

 of which cash and cash equivalents

 239.4

223.9

+ 7%

Liabilities

 971.7

849.2

+ 14%

  of which financial liabilities

159.3

135.6

 + 17%

Shareholders` equity ³

 393.5

366.2

 + 7%

Equity ratio ³ (in %)

 28.8

30.1

 - 4%

Workforce at the reporting date

 12,760

11,110

 + 15%

																		 
¹ The prior-year figures have been adjusted for comparison purposes, in accordance with the provisions of IFRS 5
² From continuing operations
³ Incl. minorities